Leukemia, Myelodysplasia, Transplantation
Conference Coverage
Can AML patients be too old for cell transplantation?
From the Journals
Study: Complications from childhood ALL and its treatment are common, but can be managed
Feature
A uniquely patient-focused take on treating AML in older adults
Conference Coverage
Clinical factors and treatment tied to COVID-19 mortality in cancer patients
Analyses of CCC19 data revealed factors linked to mortality in patients with COVID-19 and cancer.
From the Journals
Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapies
Clinical Insights
The scope of under- and overtreatment in older adults with cancer
From the Journals
Orthopedic problems in children can be the first indication of acute lymphoblastic leukemia
From the Journals
Cancer disparities: One of the most pressing public health issues
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.
From the Journals
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL
Study also validated the prognostic value of two previously studied biomarkers.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Conference Coverage
AML maintenance: It’s now a thing